Jacobs Levy Equity Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.4M Sell
2,088,492
-181,886
-8% -$948K 0.04% 316
2025
Q4
$14M Sell
2,270,378
-172,534
-7% -$1.25M 0.05% 261
2025
Q3
$17.7M Buy
2,442,912
+1,492,405
+157% +$8.86M 0.07% 216
2025
Q2
$5.05M Buy
+950,507
New +$5.61M 0.02% 431
2021
Q1
Sell
-62,922
Closed -$1.24M 1085
2020
Q4
$1.24M Sell
62,922
-711,567
-92% -$11.5M 0.01% 668
2020
Q3
$10.1M Buy
774,489
+645,116
+499% +$8.16M 0.1% 210
2020
Q2
$1.47M Buy
+129,373
New +$1.84M 0.02% 587
2017
Q3
Sell
-65,900
Closed -$1.7M 1001
2017
Q2
$1.7M Sell
65,900
-219,930
-77% -$4.67M 0.04% 465
2017
Q1
$5.49M Buy
285,830
+64,200
+29% +$1.14M 0.11% 234
2016
Q4
$3.69M Sell
221,630
-231,996
-51% -$4.2M 0.07% 299
2016
Q3
$9.34M Buy
+453,626
New +$11.5M 0.17% 174

Other funds holding MYGN